Moderna Ruling Misses On 'Products Sold To US Government'
On Nov. 2, the U.S. District Court for the District of Delaware, in Arbutus Biopharma Corp. v. Moderna Inc., refused to dismiss patent infringement claims against Moderna for its sale of COVID-19...To view the full article, register now.
Already a subscriber? Click here to view full article